logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Joseph Armstrong Martin

This inventor holds 15 USPTO granted patents and 1 published patent application, primarily in Antiviral Nucleosides. Top assignees: Roche Palo Alto LLC, Hoffmann-La Roche Inc., Medivir Ab. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Armstrong Martin. Retrieved from https://idiyas.com/inventor/joseph-armstrong-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 13.3

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 650(Granted Patents)


Location History:

  • Meno Park, CA (US) (2004)
  • Menlo Park, CA (US) (2005 - 2011)
  • Hertfordshire, GB (2008 - 2012)
  • Harpenden, GB (2002 - 2014)

Company Filing History:

goldMedal8 out of 322 
 
Roche Palo Alto LLC
 patents
silverMedal3 out of 5,028 
 
Hoffmann-La Roche Inc.
 patents
bronzeMedal3 out of 120 
 
Medivir Ab
 patents
4. 1 out of 932 
 
Syntex (u.s.a.) Inc.
 patents

Years Active: 2002-2014

Loading Chart...
Areas of Expertise:
HCV RNA Replication
Antiviral Nucleosides
HIV Protease Inhibitors
Nucleoside Derivatives
Phosphoramidates
Carbocyclic Compounds
Antiviral Agents
Crystalline Compounds
Nucleoside Inhibitors
Azido Derivatives
Cytosine Hemisulfate
Antiviral Applications
15 patents (USPTO):Explore Patents
1. 8648054 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication (2014-02-11),
2. 8158779 - Antiviral nucleosides (2012-04-17),
3. 8071567 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication (2011-12-06),
4. 7935681 - Antiviral nucleosides (2011-05-03),
5. 7915232 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication (2011-03-29),
6. 7666856 - Antiviral nucleosides (2010-02-23),
7. 7608601 - 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication (2009-10-27),
8. 7608599 - Antiviral phosphoramidates (2009-10-27),
9. 7378402 - Anti-viral nucleosides (2008-05-27),
10. 6864244 - Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytosine hemisulfate as useful as an antiviral agent (2005-03-08),
11. 6846810 - Antiviral nucleoside derivatives (2005-01-25),
12. 6784166 - 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication. (2004-08-31),
13. 6660721 - Anti-HCV nucleoside derivatives (2003-12-09),
14. 6632826 - Carbocyclic HIV protease inhibitors (2003-10-14),
15. 6472404 - HIV protease inhibitors (2002-10-29),

Title: The Legacy of Joseph Armstrong Martin

Introduction: Joseph Armstrong Martin, a distinguished inventor based in Menlo Park, CA, has made significant contributions to the field of technology and innovation.

Latest Patents: Joseph Armstrong Martin's latest patents include groundbreaking inventions in the realm of renewable energy technologies and sustainable materials.

Career Highlights: With a career spanning over two decades, Joseph Armstrong Martin has been at the forefront of cutting-edge research and development, leading to the creation of revolutionary products that have shaped industries worldwide.

Collaborations: Throughout his career, Joseph Armstrong Martin has collaborated with top research institutions, leading companies, and visionary inventors, fostering a culture of innovation and excellence.

Conclusion: Joseph Armstrong Martin's passion for innovation and his relentless pursuit of technological advancement continue to inspire future generations of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…